S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy
Clinical trial NCT00630968 · COMPLETED
Trial details
- NCT number
- NCT00630968
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2000-08-01
- Primary completion
- 2004-02-01
- Enrollment
- 1541
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.